As life science becomes increasingly interdisciplinary, the CPG Scientific Events Annual Meeting continues its long-held reputation for bringing together leading scientists from the all over the world who work at the interface of the life, medical, and computational sciences.
Welcome to the 2nd Global Congress on Cell Structural and Molecular Biology on June 01-02, 2020 at Stockholm, Sweden. This international conference will provide an unrivaled chance to interact and exchange information with worldwide leaders in the fields of cell and molecular biology. This dynamic two-day Meeting provides attendees with opportunities to share their latest research findings and learn the newest emerging techniques and applications.
Despite its nearly 100+ attendees, the Meeting is noted for maintaining its small meeting feels beginning with the keynote presentations, which allow attendees to meet renowned scientists and researchers within their scientific communities. It is also known for its vitality, demonstrated by the 30+ plenary presenters, many highly interactive daily poster presentations by speakers selected from submitted abstracts, there are many career development symposia and special sessions for those working in academia, industry, and agencies throughout the world, and its advocacy and education programs.
Have you ever been ill? Even if it was a 'tummy bug' it will have been your cells that were affected by the poisonous chemicals or toxins from bacteria cells in the bad food.You may know of someone who has been ill with a disease or disorder such as meningitis, malaria, diabetes, a type of cancer, cystic fibrosis, or Alzheimer’s disease. All these diseases and disorders are caused by problems at a cell or molecular level. Physical damage such as a burn or broken bone also causes damage at cell level.
By understanding how cells work in healthy and diseased states, cell biologists working in animal, plant and medical science will be able to develop new vaccines, more effective medicines, plants with improved qualities and through increased knowledge a better understanding of how all living things live. Eventually it will be possible to produce a 'health forecast' by analyzing database of genetic and cell information. Using this you will be able to take more control over your health in a preventive way. But cell biology is not just about disease. It has greatly assisted the human fertility programme. DNA testing has been used in archaeology to provide evidence that a living person is related to a long dead ancestor. In plant science it has been used to show that two plants that look different have the same genetic origins. Forensic medicine uses cell biology and DNA fingerprinting to help solve murders and assaults. Neither the courts of law nor the criminals can escape the importance of cell biology. Biotechnology uses techniques and information from cell biology to genetically modify crops to produce alternative characteristics; to clone plants and animals; to produce and ensure high quality food is available at lower costs; to produce purer medicines and in time organs for the many people who need transplants.
The worldwide structural biology and molecular modeling techniques market accounted for USD 2.52 billion in 2015 and is predicted to grow at a CAGR of 18.2% over the approaching years. The market is preponderantly driven by rise within the prevalence of chronic diseases with acquired drug resistance that exemplifies the need for new and advanced therapeutics. This has resulted within the high clinical urgency to include structural biology & molecular modeling techniques to develop a brand new generation of drugs. For instance, in 2011, researchers from the University of Natural Resources and Life Sciences in Austria carried out molecular dynamics simulations to study the activity of humanized antibodies (Ab2/3H6), this is believed to neutralize HIV-1. The results generated through this simulation with success know back mutation sites in antibodies to alter protein antibody immunization while not the loss of specificity and binding affinity in them.
In addition, the high drug rate related to late-phase clinical trials in drug development could be vital contributor of the elevated prices that is any plausible propel the demand for modeling techniques to scale back the likelihood of drug failure. This is often achieved through the utilization of prediction software that provides detailed insights of proteins with 3-D molecular structures and predicts their binding conformation & biological interactions.